SAB Biotherapeutics (SABS) to Release Earnings on Thursday
SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($1.16) per share and revenue of $0.12 million for the quarter. SAB Biotherapeutics Stock Down 7.0 % Shares of SABS opened at $1.60 on […]
